{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:08:27Z","timestamp":1794917307414,"version":"4.9.1"},"reference-count":72,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["R01CA201380"],"award-info":[{"award-number":["R01CA201380"]}]},{"name":"Leukemia and Lymphoma Society","award":["1372-21"],"award-info":[{"award-number":["1372-21"]}]},{"name":"Leukemia and Lymphoma Society"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Follicular lymphoma (FL) is a B-cell malignancy with a complex tumor microenvironment that is rich in nonmalignant immune cells. We applied single-cell RNA sequencing to characterize the diverse tumor and immune cell populations of FL and identified major phenotypic subsets of FL T cells, including a cytotoxic CD4 T-cell population. We characterized four major FL subtypes with differential representation or relative depletion of distinct T-cell subsets. By integrating exome sequencing, we observed that somatic mutations are associated with, but not definitive for, reduced MHC expression on FL cells. In turn, expression of MHCII genes by FL cells was associated with significant differences in the proportions and targetable immunophenotypic characteristics of T cells. This provides a classification framework of the FL microenvironment in association with FL genotypes and MHC expression, and informs different potential immunotherapeutic strategies based upon tumor cell MHCII expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We have characterized the FL-infiltrating T cells, identified cytotoxic CD4 T cells as an important component that is associated with tumor cell\u2013intrinsic characteristics, and identified sets of targetable immune checkpoints on T cells that differed from FLs with normal versus low MHC expression.<\/jats:p>\n                    <jats:p>See related commentary by Melnick, p. 374.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 369<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-21-0075","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T10:34:51Z","timestamp":1658313291000},"page":"428-443","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-2507","authenticated-orcid":false,"given":"Guangchun","family":"Han","sequence":"first","affiliation":[{"name":"1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-461X","authenticated-orcid":false,"given":"Qing","family":"Deng","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-2096","authenticated-orcid":false,"given":"Mario L.","family":"Marques-Piubelli","sequence":"additional","affiliation":[{"name":"3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-0277","authenticated-orcid":false,"given":"Enyu","family":"Dai","sequence":"additional","affiliation":[{"name":"1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-2877","authenticated-orcid":false,"given":"Minghao","family":"Dang","sequence":"additional","affiliation":[{"name":"1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-8144","authenticated-orcid":false,"given":"Man Chun John","family":"Ma","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-9215","authenticated-orcid":false,"given":"Xubin","family":"Li","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3870-2679","authenticated-orcid":false,"given":"Haopeng","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-5234","authenticated-orcid":false,"given":"Jared","family":"Henderson","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-7764","authenticated-orcid":false,"given":"Olga","family":"Kudryashova","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-9370","authenticated-orcid":false,"given":"Mark","family":"Meerson","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0404-9261","authenticated-orcid":false,"given":"Sergey","family":"Isaev","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-7357","authenticated-orcid":false,"given":"Nikita","family":"Kotlov","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-8247","authenticated-orcid":false,"given":"Krystle J.","family":"Nomie","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-854X","authenticated-orcid":false,"given":"Alexander","family":"Bagaev","sequence":"additional","affiliation":[{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-1636","authenticated-orcid":false,"given":"Edwin R.","family":"Parra","sequence":"additional","affiliation":[{"name":"5Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1253-630X","authenticated-orcid":false,"given":"Luisa M.","family":"Solis Soto","sequence":"additional","affiliation":[{"name":"5Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-9233","authenticated-orcid":false,"given":"Simrit","family":"Parmar","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-7243","authenticated-orcid":false,"given":"Fredrick B.","family":"Hagemeister","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8299","authenticated-orcid":false,"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-813X","authenticated-orcid":false,"given":"Swaminathan P.","family":"Iyer","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-4583","authenticated-orcid":false,"given":"Felipe","family":"Samaniego","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-3629","authenticated-orcid":false,"given":"Raphael","family":"Steiner","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-5548","authenticated-orcid":false,"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-5562","authenticated-orcid":false,"given":"Hun","family":"Lee","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-1877","authenticated-orcid":false,"given":"Nathan H.","family":"Fowler","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"4BostonGene Corporation, Waltham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3990","authenticated-orcid":false,"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-1459","authenticated-orcid":false,"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1824-2337","authenticated-orcid":false,"given":"Jason R.","family":"Westin","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-4914","authenticated-orcid":false,"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-8610","authenticated-orcid":false,"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[{"name":"3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-0266","authenticated-orcid":false,"given":"Linghua","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"6UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-9472","authenticated-orcid":false,"given":"Michael R.","family":"Green","sequence":"additional","affiliation":[{"name":"1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"6UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas."},{"name":"7Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"2025112416535027600_bib1","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest"},{"key":"2025112416535027600_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MOH.0000000000000049","article-title":"Common progenitor cells in mature B-cell malignancies: implications for therapy","volume":"21","author":"Green","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"2025112416535027600_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib4","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/2159-8290.CD-19-1448","article-title":"CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade","volume":"10","author":"Wang","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","article-title":"Human germinal center transcriptional programs are de-synchronized in B cell lymphoma","volume":"19","author":"Milpied","year":"2018","journal-title":"Nat Immunol"},{"key":"2025112416535027600_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2018-08-862292","article-title":"Single-cell RNA-seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints","volume":"133","author":"Andor","year":"2019","journal-title":"Blood"},{"key":"2025112416535027600_bib7","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1182\/blood.2020009855","article-title":"Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma","volume":"137","author":"Haebe","year":"2021","journal-title":"Blood"},{"key":"2025112416535027600_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41556-020-0532-x","article-title":"Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels","volume":"22","author":"Roider","year":"2020","journal-title":"Nat Cell Biol"},{"key":"2025112416535027600_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.20121190","article-title":"Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of eomesodermin","volume":"210","author":"Curran","year":"2013","journal-title":"J Exp Med"},{"key":"2025112416535027600_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20120532","article-title":"Induction of tumoricidal function in CD4+\u00a0T cells is associated with concomitant memory and terminally differentiated phenotype","volume":"209","author":"Hirschhorn-Cymerman","year":"2012","journal-title":"J Exp Med"},{"key":"2025112416535027600_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025112416535027600_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/blood-2013-07-512392","article-title":"Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma","volume":"123","author":"Brodtkorb","year":"2014","journal-title":"Blood"},{"key":"2025112416535027600_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025112416535027600_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"2025112416535027600_bib15","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","article-title":"EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations","volume":"20","author":"Guo","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2025112416535027600_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.20132120","article-title":"Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy","volume":"211","author":"Oricchio","year":"2014","journal-title":"J Exp Med"},{"key":"2025112416535027600_bib17","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1200\/JCO.2017.75.4648","article-title":"Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma","volume":"35","author":"Dreyling","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025112416535027600_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2020.274258","article-title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","volume":"107","author":"Ma","year":"2021","journal-title":"Haematologica"},{"key":"2025112416535027600_bib19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"key":"2025112416535027600_bib20","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1182\/blood-2011-03-344374","article-title":"PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma","volume":"118","author":"Gomez-Abad","year":"2011","journal-title":"Blood"},{"key":"2025112416535027600_bib21","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"key":"2025112416535027600_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/cas.12392","article-title":"Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis","volume":"105","author":"Takata","year":"2014","journal-title":"Cancer Sci"},{"key":"2025112416535027600_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s43018-020-0080-0","article-title":"The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing","volume":"1","author":"Parsa","year":"2020","journal-title":"Nat Cancer"},{"key":"2025112416535027600_bib24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"2025112416535027600_bib25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","article-title":"Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures","volume":"11","author":"Kotlov","year":"2021","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"2025112416535027600_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2017-08-737361","article-title":"Chromatin modifying gene mutations in follicular lymphoma","volume":"131","author":"Green","year":"2018","journal-title":"Blood"},{"key":"2025112416535027600_bib28","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2025112416535027600_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"2025112416535027600_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"2025112416535027600_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nature21433","article-title":"Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens","volume":"543","author":"Khodadoust","year":"2017","journal-title":"Nature"},{"key":"2025112416535027600_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.15708","article-title":"Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era","volume":"184","author":"Rivas-Delgado","year":"2019","journal-title":"Br J Haematol"},{"key":"2025112416535027600_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bjh.15805","article-title":"Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population","volume":"185","author":"Magnano","year":"2019","journal-title":"Br J Haematol"},{"key":"2025112416535027600_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/asheducation-2018.1.194","article-title":"Novel immunotherapy approaches to follicular lymphoma","volume":"2018","author":"Flowers","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2025112416535027600_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"2025112416535027600_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2017.00019","article-title":"Cytotoxic CD4 T cells-friend or foe during viral infection?","volume":"8","author":"Juno","year":"2017","journal-title":"Front Immunol"},{"key":"2025112416535027600_bib37","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"2025112416535027600_bib38","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.18.02365","article-title":"Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration","volume":"37","author":"Tobin","year":"2019","journal-title":"J Clin Oncol"},{"key":"2025112416535027600_bib39","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI64859","article-title":"Depleting tumor-specific tregs at a single site eradicates disseminated tumors","volume":"123","author":"Marabelle","year":"2013","journal-title":"J Clin Invest"},{"key":"2025112416535027600_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class ii and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025112416535027600_bib41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/2159-8290.CD-19-0116","article-title":"Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma","volume":"10","author":"Mondello","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib42","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.1619555114","article-title":"Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth","volume":"114","author":"Hashwah","year":"2017","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2025112416535027600_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib44","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"key":"2025112416535027600_bib45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"2025112416535027600_bib46","first-page":"0346v3","article-title":"UMAP: uniform manifold approximation and projection for dimension reduction","volume":"1802","author":"McInnes","year":"2020","journal-title":"arxiv"},{"key":"2025112416535027600_bib47","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2025112416535027600_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025112416535027600_bib49","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"2025112416535027600_bib50","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"2025112416535027600_bib51","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"2025112416535027600_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12859-015-0613-1","article-title":"tcR: an R package for T cell receptor repertoire advanced data analysis","volume":"16","author":"Nazarov","year":"2015","journal-title":"BMC Bioinf"},{"key":"2025112416535027600_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-17-0256","article-title":"TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence","volume":"7","author":"Reuben","year":"2017","journal-title":"Cancer Discov"},{"key":"2025112416535027600_bib54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"2025112416535027600_bib55","first-page":"3997","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWAMEM","volume":"1303","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"2025112416535027600_bib56","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2025112416535027600_bib57","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"2025112416535027600_bib58","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature08250","article-title":"Targeted capture and massively parallel sequencing of 12 human exomes","volume":"461","author":"Ng","year":"2009","journal-title":"Nature"},{"key":"2025112416535027600_bib59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"2025112416535027600_bib60","doi-asserted-by":"crossref","first-page":"e8746","DOI":"10.15252\/msb.20188746","article-title":"Current best practices in single-cell RNA-seq analysis: a tutorial","volume":"15","author":"Luecken","year":"2019","journal-title":"Mol Syst Biol"},{"key":"2025112416535027600_bib61","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From louvain to leiden: guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci Rep"},{"key":"2025112416535027600_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"key":"2025112416535027600_bib63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2025112416535027600_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"2025112416535027600_bib65","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1158\/1538-7445.AM2020-853","article-title":"Abstract 853: novel machine learning based deconvolution algorithm results in accurate description of tumor microenvironment from bulk RNAseq","volume":"80","author":"Zaytcev","year":"2020","journal-title":"Cancer Res"},{"key":"2025112416535027600_bib66","doi-asserted-by":"crossref","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"2025112416535027600_bib67","doi-asserted-by":"crossref","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025112416535027600_bib68","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2025112416535027600_bib69","first-page":"164","article-title":"PHYLIP \u2013 phylogeny inference package (Version 3.2)","volume":"5","author":"Felsenstein","year":"1989","journal-title":"Cladistics"},{"key":"2025112416535027600_bib70","doi-asserted-by":"crossref","first-page":"667067","DOI":"10.3389\/fmolb.2021.667067","article-title":"Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues","volume":"8","author":"Hernandez","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2025112416535027600_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/cancers12020255","article-title":"Procedural requirements and recommendations for multiplex immunofluorescence tyramide signal amplification assays to support translational oncology studies","volume":"12","author":"Parra","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025112416535027600_bib72","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/hupa.2002.127438","article-title":"Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma","volume":"33","author":"Hedvat","year":"2002","journal-title":"Hum Pathol"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-21-0075\/3182729\/bcd-21-0075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/5\/428\/3267394\/428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/5\/428\/3267394\/428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:54:05Z","timestamp":1764021245000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/3\/5\/428\/708353\/Follicular-Lymphoma-Microenvironment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,6,10]]},"published-print":{"date-parts":[[2022,9,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-21-0075","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.22545648.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550995.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22545651.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550995","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.22545651","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22545648","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}